Uniondale, N.Y. – September 15, 2026 -- Marquis Who's Who has included Monib A. Zirvi, MD, PhD, in its biographical volumes, recognizing more than two decades of work in dermatology and diagnostic genetics as a related patent dispute involving Illumina Inc. reaches final resolution.
Zirvi Has Practiced Dermatology at Summit Health Since 2004
Dr. Zirvi has served as a dermatologist with Summit Health and as an attending physician at Atlantic Health System's Overlook Medical Center since 2004, focusing on general dermatology, skin cancer detection and hair and nail disorders. Summit Health named him among its 2026 Castle Connolly Top Doctors. He is board certified by the American Board of Dermatology and holds a courtesy instructor appointment in microbiology and immunology at Weill Cornell Medicine, where he earned his MD and PhD.
Zirvi's Graduate Research Contributed to Universal DNA Array Development
During his doctoral work, Dr. Zirvi helped design the original ZipCode DNA sequences and contributed to the Universal DNA Array, technology that advanced genetic diagnostics and microarray-based testing. He holds multiple patents in DNA diagnostics, work that later became the subject of litigation.
Third Circuit Affirms Dismissal of Zirvi v. Illumina on Claim-Preclusion Grounds
The case, filed in the U.S. District Court for the District of New Jersey, alleged intellectual property attribution issues and an asserted attorney-client relationship tied to Dr. Zirvi's role as a fact witness in earlier patent litigation between Cornell University and Illumina Inc. Defendants contested the allegations. In October 2025, the U.S. Court of Appeals for the Third Circuit affirmed the district court's dismissal on claim-preclusion grounds, and the U.S. Supreme Court subsequently denied review.
Magistrate Judge Orders Unsealing of 1,679-Page Email Exhibit in June 2026
In a separate public-access proceeding, a magistrate judge ordered the unsealing of a 1,679-page email exhibit containing correspondence among Dr. Zirvi, Cornell representatives, attorneys and others connected to the earlier patent case. The ruling addressed only access to the court record and did not disturb the underlying dismissal.
"Making this record public allows interested readers to review the contemporaneous communications for themselves," Dr. Zirvi said, adding that his commitment to scientific integrity and transparency in professional relationships continues despite the litigation's conclusion.